Results 21 to 30 of about 11,423 (215)

Clinical efficacy and safety of low‐dose oral minoxidil versus topical solution in the improvement of androgenetic alopecia: A randomized controlled trial

Journal of Cosmetic Dermatology, 2023
Topical minoxidil is the recommended first‐line pharmacologic treatment for male and female pattern hair loss. However, low‐dose oral minoxidil has been used off‐label with good clinical efficacy and safety.
A. Asilian, Aida Farmani, Mina Saber
semanticscholar   +1 more source

Relative Efficacy of Minoxidil and the 5-α Reductase Inhibitors in Androgenetic Alopecia Treatment of Male Patients: A Network Meta-analysis.

JAMA dermatology, 2022
Importance There are knowledge gaps regarding the relative efficacy of 3 commonly used drugs for androgenetic alopecia (AGA), namely, minoxidil and the two 5-α reductase inhibitors dutasteride and finasteride. Objective To examine the relative efficacy
Aditya K. Gupta, M. Venkataraman, M. Talukder, M. Bamimore   +3 more
semanticscholar   +1 more source

Combination of adipose-derived stem cell conditioned media and minoxidil for hair regrowth in male androgenetic alopecia: a randomized, double-blind clinical trial

Stem cell research & therapeutics, 2023
Introduction Treatments for AGA have yet to produce satisfactory outcomes and may cause intolerable side effects. Recent studies have reported that adipose tissue-derived stem cell conditioned media (ADSC-CM) could induce hair growth and regeneration ...
Lili Legiawati, L. Suseno, I. B. Sitohang, S. Yusharyahya, J. Pawitan, I. Liem, Trie Kurniawati, Athaya Ardelia, Kanya Paramastri   +8 more
semanticscholar   +1 more source

Efficacy of the association of topical minoxidil and topical finasteride compared to their use in monotherapy in men with androgenetic alopecia: A prospective, randomized, controlled, assessor blinded, 3‐arm, pilot trial

Journal of Cosmetic Dermatology, 2023
Topical minoxidil (MNX) 2%–5% and oral finasteride (F) 1 mg/day are the only two pharmacological treatments authorized for androgenetic alopecia (AGA). Recently, a 2.2 mg/mL topical formulation of F was developed to minimize the systemic adverse effects ...
A. Rossi, G. Caro
semanticscholar   +1 more source

Injections of platelet‐rich plasma prepared by automatic blood cell separator combined with topical 5% minoxidil in the treatment of male androgenetic alopecia

Skin research and technology, 2023
Platelet‐rich plasma (PRP) has been increasingly accepted as a potential therapy in the treatment of androgenetic alopecia (AGA), However, there remains a dearth of data on the effectiveness of PRP prepared by automatic blood cell separator with a ...
Wei Wei, Yuanjing Zhang, Binman Long, Yuanyuan Zhang, Chi Zhang, Siping Zhang   +5 more
semanticscholar   +1 more source

Evaluating the efficacy and safety of combined microneedling therapy versus topical Minoxidil in androgenetic alopecia: a systematic review and meta-analysis

Archives of Dermatological Research
This study evaluates the efficacy and safety of the combined microneedling (CMNT) with minoxidil versus minoxidil monotherapy for the treatment of androgenetic alopecia (AGA), with a focus on the impact of microneedling parameters on treatment outcomes ...
Khalid M. A. Ahmed, Y. Kozaa, M. Abuawwad, Alaa I. Al-Najdawi, Yomna W. Mahmoud, Ahmed M. Ahmed, Mohammad J. J. Taha, Tamara Fadhli, Angeliki Giannopoulou   +8 more
semanticscholar   +1 more source

Effect of High-Dose Topical Minoxidil on Erythrocyte Quality in SKH1 Hairless Mice

Animals, 2020
SKH1 hairless mice are widely used in carcinogenesis and dermatology research due to their bare skin, as exposure to different agents is facilitated. Minoxidil is a cosmetic drug that is recognized as a mitogenic agent, and mitogens are suggested to have
Eduardo Naranjo-Vázquez, María Guadalupe Sánchez-Parada, Belinda Claudia Gómez-Meda, Ana Lourdes Zamora-Perez, Martha Patricia Gallegos-Arreola, Ana Elizabeth González-Santiago, Guillermo Moisés Zúñiga-González   +6 more
doaj   +1 more source

Oral Minoxidil vs Topical Minoxidil for Male Androgenetic Alopecia: A Randomized Clinical Trial.

JAMA dermatology
Importance There has been increased interest in low-dose oral minoxidil for androgenetic alopecia (AGA) treatment. However, the efficacy of oral minoxidil for male AGA is yet to be evaluated in comparative therapeutic trials.
M. Penha, H. Miot, Michal Kasprzak, P. Müller Ramos   +3 more
semanticscholar   +1 more source

Randomized controlled trial to compare the efficacy of oral minoxidil 1.25 mg versus 2.5 mg versus topical 5% minoxidil in androgenetic alopecia

Dermatologica Sinica
Background: The first-line pharmacologic treatment for both male and female pattern hair loss is topical minoxidil. Nonetheless, off-label usage of low-dose oral minoxidil has demonstrated good clinical efficacy and safety.
Bhumika Mahawar, Ashish Ramchandra Deshmukh   +1 more
doaj   +1 more source

Minoxidil in trichological practice

Медицинский совет, 2018
Management of patients with alopecia is still a challenging task. Minoxidil is a pyrimidine derivative, a potent KATP channel opener, and has been shown to act as a vasodilating agent.
O. Yu. Olisova, I. P. Gostroverkhova
doaj   +1 more source